135 related articles for article (PubMed ID: 11790468)
1. Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine antinociception in rats.
Baker L; Ratka A
Pain; 2002 Jan; 95(1-2):65-74. PubMed ID: 11790468
[TBL] [Abstract][Full Text] [Related]
2. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat.
Smith GD; Smith MT
Pain; 1995 Jul; 62(1):51-60. PubMed ID: 7478708
[TBL] [Abstract][Full Text] [Related]
3. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
[TBL] [Abstract][Full Text] [Related]
4. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
5. Central metabolism as a potential origin of sex differences in morphine antinociception but not induction of antinociceptive tolerance in mice.
Gabel F; Hovhannisyan V; Andry V; Goumon Y
Br J Pharmacol; 2023 Apr; 180(7):843-861. PubMed ID: 34986502
[TBL] [Abstract][Full Text] [Related]
6. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
[TBL] [Abstract][Full Text] [Related]
7. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
Faura CC; Olaso JM; Cabanes CG; Horga JF
Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
[TBL] [Abstract][Full Text] [Related]
8. Morphine-3-glucuronide causes antinociceptive cross-tolerance to morphine and increases spinal substance P expression.
Blomqvist KJ; Viisanen H; Ahlström FHG; Jokinen V; Sidorova YA; Suleymanova I; Rauhala PV; Kalso EA; Lilius TO
Eur J Pharmacol; 2020 May; 875():173021. PubMed ID: 32112778
[TBL] [Abstract][Full Text] [Related]
9. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
Smith GD; Smith MT
J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
[TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: modulatory role of testosterone via morphine clearance.
South SM; Wright AW; Lau M; Mather LE; Smith MT
J Pharmacol Exp Ther; 2001 Apr; 297(1):446-57. PubMed ID: 11259573
[TBL] [Abstract][Full Text] [Related]
11. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
Doyle HH; Murphy AZ
Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
[TBL] [Abstract][Full Text] [Related]
12. Effect of prior morphine-3-glucuronide exposure on morphine disposition and antinociception.
Ouellet DM; Pollack GM
Biochem Pharmacol; 1997 May; 53(10):1451-7. PubMed ID: 9260872
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
14. Morphine glucuronidation increases its analgesic effect in guinea pigs.
Oliveira A; Pinho D; Albino-Teixeira A; Medeiros R; Dinis-Oliveira RJ; Carvalho F
Life Sci; 2014 Jul; 109(2):104-10. PubMed ID: 24968302
[TBL] [Abstract][Full Text] [Related]
15. Changing M3G/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatment.
Andersen G; Christrup LL; Sjøgren P; Hansen SH; Jensen NH
J Pain Symptom Manage; 2002 Feb; 23(2):161-4. PubMed ID: 11844638
[TBL] [Abstract][Full Text] [Related]
16. Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-Dawley rats: differences between the tail flick and hot plate nociceptive tests.
South SM; Edwards SR; Smith MT
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):20-8. PubMed ID: 18671713
[TBL] [Abstract][Full Text] [Related]
17. Effect of uranyl nitrate-induced renal failure on morphine disposition and antinociceptive response in rats.
Van Crugten JT; Somogyi AA; Nation RL
Clin Exp Pharmacol Physiol; 2000; 27(1-2):74-9. PubMed ID: 10696532
[TBL] [Abstract][Full Text] [Related]
18. Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.
Gardmark M; Karlsson MO; Jonsson F; Hammarlund-Udenaes M
J Pharm Sci; 1998 Jul; 87(7):813-20. PubMed ID: 9649348
[TBL] [Abstract][Full Text] [Related]
19. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study.
Hewett K; Dickenson AH; McQuay HJ
Pain; 1993 Apr; 53(1):59-63. PubMed ID: 8316391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
